Plum Island Animal Disease Center, Foreign Animal Disease Research Unit, Agricultural Research Service, US Department of Agriculture, Greenport, NY 11944, United States.
Vaccine. 2012 Feb 21;30(9):1690-701. doi: 10.1016/j.vaccine.2011.12.082. Epub 2012 Jan 6.
Recombinant replication-defective human adenovirus type 5 (Ad5) vaccines containing capsid-coding regions from foot-and-mouth disease virus (FMDV) have been demonstrated to induce effective immune responses and provide homologous protective immunity against FMDV in cattle. However, basic mechanisms of Ad5-FMDV vaccine function including virus tropism, transgene expression, and antigen presentation, remain incompletely understood. The current study characterized the dynamics of Ad5 viral vector (Ad5-FMDV-A24 and Ad5-luciferase) infection in cell lines and early post-inoculation vector-host interactions in cattle. Adenovirus dissemination was described utilizing novel rPCR, rRT-PCR, luminometry, and immunomicroscopy techniques. In vitro infection of human and bovine cells with both Ad5 vectors resulted in dose-dependent detection of vector DNA, mature mRNA transcripts, and transgene-encoded proteins. Subsequent to intramuscular inoculation of cattle, Ad5 and transgene products were detected at the injection sites of all animals at all time-points examined (6, 24, and 48 hpi). Microscopically, injection sites were characterized by marked infiltrates of interstitium consisting of predominantly large mononuclear cells. Immunomicroscopy indicated these cells infrequently contained adenovirus and/or transgenic proteins and were phenotypically consistent with antigen-presenting cells (macrophages and dendritic cells). Vector DNA and mature mRNA transcripts were first detected at the draining and local lymph nodes as early as 6 hpi and systemically at 24 hpi. These results provide novel insights for understanding Ad5-mediated immunity against FMDV using novel techniques that will contribute to ongoing efforts for the improvement of future Ad-FMDV vaccine platforms.
含口蹄疫病毒(FMDV)衣壳编码区的复制缺陷型人 5 型腺病毒(Ad5)重组疫苗已被证明能在牛中诱导有效的免疫应答,并提供针对 FMDV 的同源保护免疫。然而,Ad5-FMDV 疫苗功能的基本机制,包括病毒嗜性、转基因表达和抗原呈递,仍不完全清楚。本研究描述了 Ad5 病毒载体(Ad5-FMDV-A24 和 Ad5-荧光素酶)在细胞系中的感染动力学以及牛接种后早期的载体-宿主相互作用。利用新型 rPCR、rRT-PCR、发光计和免疫显微镜技术描述了腺病毒的传播情况。两种 Ad5 载体对人源和牛源细胞的体外感染导致载体 DNA、成熟 mRNA 转录本和转基因编码蛋白的剂量依赖性检测。在牛肌肉内接种后,在所有检查时间点(6、24 和 48 hpi)的所有动物的注射部位都检测到 Ad5 和转基因产物。显微镜下,注射部位的特点是间质有明显浸润,主要由大单核细胞组成。免疫显微镜显示,这些细胞很少含有腺病毒和/或转基因蛋白,表型与抗原呈递细胞(巨噬细胞和树突状细胞)一致。早在 6 hpi 时,在引流和局部淋巴结中就首次检测到载体 DNA 和成熟 mRNA 转录本,在 24 hpi 时在全身检测到。这些结果为使用新型技术理解 Ad5 介导的针对 FMDV 的免疫提供了新的见解,这些技术将有助于改进未来 Ad-FMDV 疫苗平台的持续努力。